INCONTINENCE CONTROL SYSTEM (INTERSTIM®) FOR THE FECAL INCONTINENCE TREATMENT AT HEALTHCARE PUBLIC SECTOR IN MEXICO

Author(s)

Cerezo O1, Orozco D2, Saracho A2, Lemus F2, Flores B2, Valencia J3, Figueroa A2
1Medtronic, MX, Mexico, 2Pharmamanagement EAS S de RL de CV, Cuidad de México, Mexico, 3Medtronic, Miami, FL, USA

OBJECTIVES:: The social impact of fecal incontinence (FI) could be devastating, that's the reason why FI could decrease QoL and trigger emotional issues. At the same time FI causes economic problems for the healthcare sector. Nowadays the Mexican clinical practice recommends graciloplasty for those patients who have failed to esfinteroplasty. In this sense, to demonstrate the suitability and the value for money of new alternatives, we designed and executed a full economic evaluation to assess the Incontinence Control System (Interstim®) for the treatment of fecal incontinence vs SoC available at healthcare public sector in Mexico.

Conference/Value in Health Info

2017-09, ISPOR Latin America 2017, Sao Paulo, Brazil

Value in Health, Vol. 20, No. 9 (October 2017)

Code

PMD29

Topic

Economic Evaluation

Topic Subcategory

Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

Gastrointestinal Disorders, Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×